Vicarious Surgical to Present at the Gilmartin Group Emerging Growth Company Showcase
07 Septembre 2023 - 10:30PM
Business Wire
Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”)
(NYSE: RBOT, RBOT WS), a next-generation robotics technology
company seeking to improve patient outcomes as well as both the
cost and efficiency of surgical procedures, today announced the
Company will present at the Gilmartin Group Emerging Growth Company
Showcase, taking place virtually.
Management is scheduled to participate in a fireside chat on
Thursday, September 21, 2023, at 10:00 am ET. Interested parties
can access a live and archived webcast of the presentation on the
“Investors” section of the company’s website at
https://investor.vicarioussurgical.com.
About Vicarious Surgical
Founded in 2014, Vicarious Surgical is a next generation
robotics company developing a disruptive technology with the goals
of increasing the efficiency of surgical procedures, improving
patient outcomes, and reducing healthcare costs. The Company’s
novel surgical approach uses proprietary human-like surgical robots
to transport surgeons inside the patient to perform minimally
invasive surgery. The Company is led by an experienced team of
technologists, medical device professionals and physicians, and is
backed by technology luminaries including Bill Gates, Vinod
Khosla’s Khosla Ventures, Innovation Endeavors, Jerry Yang’s AME
Cloud Ventures, Sun Hung Kai & Co. Ltd and Philip Liang’s E15
VC. The Company is headquartered in Waltham, Massachusetts. Learn
more at www.vicarioussurgical.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230907593069/en/
Investor Contact Kaitlyn Brosco
Kbrosco@vicarioussurgical.com
Marissa Bych Gilmartin Group Marissa@gilmartinir.com
Press and Media Inquiries Abby Mayo for Matter Health
Matter Communications media@vicarioussurgical.com
Vicarious Surgical (NYSE:RBOT)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025
Vicarious Surgical (NYSE:RBOT)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025